-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cancer was one of the main risk factors for neo-pneumonia death during the neo-pneumonia virus pandemic.
cause of death in patients with multiple myeloma (MM) is a side infection.
, the prognosis of patients with multiple myeloma infected with the new coronary pneumonia virus has attracted much attention.
The study retrospectively described baseline characteristics and re-return data of 650 cases of plasma cell disease collected by the International Myeloma Society to understand the major challenges faced by myeloma patients during the neocyto pneumonia virus pandemic.
An analysis of patients with plasma cell disease treated inpatients found that almost all (96%) of the hospitalized patients (69 years old) had multiple myeloma, about 36% had been diagnosed within the last two years (2019-2020) and 54% were receiving first-line treatment.
33% of patients with sources, mortality and associated risk factors have died, with significant geographical differences, with mortality rates varying from 27% to 57% in hospitalized patients.
single-variable analysis found that age, IsS3, high-risk diseases, kidney disease, poor myeloma control (active or progressive diseases), and one or more combinations were risk factors for higher mortality.
the transplant history, including the transplant history within one year of the diagnosis of neo-coronary pneumonia, or other anti-MM treatments, were not related to prognostication.
multivariable analysis found that only age, high-risk MM, kidney disease and MM control are still independent predictors of poor prognosms of neo-coronary pneumonia infection.
In summary, in the current pandemic of neo-pneumonia virus, the management of multiple myeloma needs to carefully consider patient and disease-related factors in order to reduce the risk of infection with neo-coronary pneumonia virus, while appropriate treatment without affecting the effectiveness of disease control.
the study provides preliminary recommendations for the treatment of patients with multiple myeloma infected with neo-coronary pneumonia.
。
